mutLBSgeneDB |
Gene summary for NOS2 |
Gene summary |
Basic gene Info. | Gene symbol | NOS2 |
Gene name | nitric oxide synthase 2, inducible | |
Synonyms | HEP-NOS|INOS|NOS|NOS2A | |
Cytomap | UCSC genome browser: 17q11.2 | |
Type of gene | protein-coding | |
RefGenes | NM_000625.4, NM_153292.1, | |
Description | NOS type IINOS, type IIhepatocyte NOSinducible NO synthaseinducible NOSnitric oxide synthase 2A (inducible, hepatocytes)nitric oxide synthase, induciblenitric oxide synthase, macrophagepeptidyl-cysteine S-nitrosylase NOS2 | |
Modification date | 20141222 | |
dbXrefs | MIM : 163730 | |
HGNC : HGNC | ||
Ensembl : ENSG00000007171 | ||
HPRD : 01225 | ||
Vega : OTTHUMG00000132445 | ||
Protein | UniProt: P35228 go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_NOS2 | |
BioGPS: 4843 | ||
Pathway | NCI Pathway Interaction Database: NOS2 | |
KEGG: NOS2 | ||
REACTOME: NOS2 | ||
Pathway Commons: NOS2 | ||
Context | iHOP: NOS2 | |
ligand binding site mutation search in PubMed: NOS2 | ||
UCL Cancer Institute: NOS2 | ||
Assigned class in mutLBSgeneDB | B: This gene belongs to targetable_mutLBSgenes. |
Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
GO ID | GO Term | PubMed ID | GO:0006527 | arginine catabolic process | 7504305 | GO:0006809 | nitric oxide biosynthetic process | 7504305 |
Top |
Ligand binding site mutations for NOS2 |
Lollipop-style diagram of mutations at LBS in amino-acid sequence. We represented ligand binding site mutations only. (You can see big image via clicking.) : non-synonymous mutation on LBS, Circle size denotes number of samples. |
Cancer type specific mutLBS sorted by frequency |
LBS | AAchange of nsSNV | Cancer type | # samples | Y489 | F488V | BRCA | 1 | H477 | H477Y | BRCA | 1 | W194 | R195H | COAD | 1 | Y491 | Q492K | HNSC | 1 | C115 | C115G | LUAD | 1 | S550 | E551D | LUAD | 1 | W90 | G91C | SKCM | 1 | S242 | A243T | STAD | 1 | M434 | T432I | STAD | 1 | F593 | F593V | STAD | 1 | Y347 | A348V | UCEC | 1 | E479 | E479D | UCEC | 1 | Q665 | E666K | UCEC | 1 |
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma. |
Top |
Protein structure related information for NOS2 |
Relative protein structure stability change (ΔΔE) using Mupro 1.1 Mupro score denotes assessment of the effect of mutations on thermodynamic stability. (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability) |
: nsSNV at non-LBS: nsSNV at LBS |
nsSNVs sorted by the relative stability change of protein structure by each mutation Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene. |
LBS | AAchange of nsSNV | Relative stability change | C115 | C115G | -1.3418068 | Y489 | F488V | -1.1144246 | W194 | R195H | -0.98937287 | E479 | E479D | -0.9696571 | Q665 | E666K | -0.91274455 | S242 | A243T | -0.80560515 | M434 | T432I | -0.8035653 | W90 | G91C | -0.78851227 | F593 | F593V | -0.68884697 | Y347 | A348V | -0.47638242 | Y491 | Q492K | -0.43931617 | H477 | H477Y | -0.17081147 | S550 | E551D | -0.13626518 |
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132) |
Structure image for NOS2 from PDB |
Top |
Differential gene expression and gene-gene network for NOS2 |
Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types |
Differential co-expressed gene network based on protein-protein interaction data (CePIN) |
Top |
Top |
Phenotype information for NOS2 |
Gene level disease information (DisGeNet) |
Disease ID | Disease name | # PubMed | Association type |
umls:C0004096 | Asthma | 32 | AlteredExpression, Biomarker, GeneticVariation |
umls:C0024530 | Malaria | 17 | AlteredExpression, Biomarker, GeneticVariation |
umls:C0020538 | Hypertension | 10 | Biomarker, GeneticVariation |
umls:C0011860 | Diabetes Mellitus, Type 2 | 9 | Biomarker, GeneticVariation |
umls:C0004352 | Autistic Disorder | 9 | Biomarker, GeneticVariation |
umls:C0038454 | Stroke | 8 | Biomarker, GeneticVariation |
umls:C0243026 | Sepsis | 7 | Biomarker, GeneticVariation |
umls:C0021368 | Inflammation | 7 | Biomarker, GeneticVariation |
umls:C0018801 | Heart Failure | 7 | Biomarker, GeneticVariation |
umls:C0027055 | Myocardial Reperfusion Injury | 6 | Biomarker, Therapeutic |
umls:C0023895 | Liver Diseases | 6 | Biomarker, GeneticVariation |
umls:C0024117 | Pulmonary Disease, Chronic Obstructive | 5 | AlteredExpression, Biomarker, GeneticVariation |
umls:C1458155 | Breast Neoplasms | 5 | AlteredExpression, Biomarker |
umls:C0004153 | Atherosclerosis | 5 | Biomarker |
umls:C0035126 | Reperfusion Injury | 4 | Biomarker |
umls:C0007786 | Brain Ischemia | 4 | Biomarker, GeneticVariation |
umls:C0085580 | Hypertension, Essential | 4 | Biomarker, GeneticVariation |
umls:C0033860 | Psoriasis | 4 | Biomarker, GeneticVariation |
umls:C0038358 | Stomach Ulcer | 4 | Biomarker |
umls:C0027051 | Myocardial Infarction | 4 | Biomarker |
umls:C0009319 | Colitis | 3 | Biomarker |
umls:C0011853 | Diabetes Mellitus, Experimental | 3 | Biomarker |
umls:C0376618 | Endotoxemia | 3 | Biomarker |
umls:C0023893 | Liver Cirrhosis, Experimental | 3 | Biomarker, Therapeutic |
umls:C0022658 | Kidney Diseases | 3 | Biomarker, GeneticVariation |
umls:C0520459 | Enterocolitis, Necrotizing | 3 | Biomarker |
umls:C0008370 | Cholestasis | 3 | Biomarker |
umls:C0003949 | Asbestosis | 2 | Biomarker |
umls:C0036983 | Shock, Septic | 2 | Biomarker |
umls:C0037116 | Silicosis | 2 | Biomarker, GeneticVariation |
umls:C0014859 | Esophageal Neoplasms | 2 | Biomarker, GeneticVariation |
umls:C0206698 | Cholangiocarcinoma | 2 | Biomarker |
umls:C0036572 | Seizures | 2 | Biomarker |
umls:C0038525 | Subarachnoid Hemorrhage | 2 | Biomarker |
umls:C0009375 | Colonic Neoplasms | 2 | Biomarker |
umls:C0013295 | Duodenal Ulcer | 2 | Biomarker |
umls:C0020429 | Hyperalgesia | 2 | Biomarker |
umls:C0024121 | Lung Neoplasms | 2 | Biomarker |
umls:C0677050 | Manganese Poisoning | 2 | Biomarker |
umls:C0027540 | Necrosis | 2 | Biomarker |
umls:C0003872 | Arthritis, Psoriatic | 1 | Biomarker, GeneticVariation |
umls:C2609414 | Acute Kidney Injury | 1 | Biomarker |
umls:C1527311 | Brain Edema | 1 | Biomarker |
umls:C0006261 | Bronchial Diseases | 1 | Biomarker |
umls:C0006434 | Burns | 1 | Biomarker |
umls:C0243050 | Cardiovascular Abnormalities | 1 | Biomarker |
umls:C0007621 | Cell Transformation, Neoplastic | 1 | Biomarker |
umls:C0008313 | Cholangitis, Sclerosing | 1 | Biomarker |
umls:C0013990 | Emphysema | 1 | Biomarker |
umls:C0017668 | Glomerulosclerosis, Focal Segmental | 1 | Biomarker |
umls:C0020452 | Hyperemia | 1 | Biomarker |
umls:C0021831 | Intestinal Diseases | 1 | Biomarker |
umls:C0751651 | Mitochondrial Diseases | 1 | Therapeutic |
umls:C0026936 | Mycoplasma Infections | 1 | Biomarker |
umls:C0206146 | Myocardial Stunning | 1 | Biomarker |
umls:C0032290 | Pneumonia, Aspiration | 1 | Biomarker |
umls:C0036330 | Schistosomiasis mansoni | 1 | Therapeutic |
umls:C0038220 | Status Epilepticus | 1 | Biomarker |
umls:C0038325 | Stevens-Johnson Syndrome | 1 | Biomarker |
umls:C0038587 | Substance Withdrawal Syndrome | 1 | Biomarker |
umls:C0042029 | Urinary Tract Infections | 1 | Biomarker |
Mutation level pathogenic information (ClinVar annotation) |
Allele ID | AA change | Clinical significance | Origin | Phenotype IDs |
Top |
Pharmacological information for NOS2 |
Gene expression profile of anticancer drug treated cell-lines (CCLE) Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient. |
Gene-centered drug-gene interaction network |
Drug information targeting mutLBSgene (Approved drugs only) |
Drug status | DrugBank ID | Name | Type | Drug structure |
Approved|nutraceutical | DB00125 | L-Arginine | Small molecule | |
Approved|nutraceutical | DB00155 | L-Citrulline | Small molecule | |
Approved|investigational|vet_approved | DB01110 | Miconazole | Small molecule | |
Approved|investigational|vet_approved | DB01234 | Dexamethasone | Small molecule | |
Experimental | DB01686 | N,N-dimethylarginine | Small molecule | |
Experimental | DB01835 | 4r-Fluoro-N6-Ethanimidoyl-L-Lysine | Small molecule | |
Experimental | DB01997 | 3-Bromo-7-Nitroindazole | Small molecule | |
Experimental | DB02044 | N-(3-(Aminomethyl)Benzyl)Acetamidine | Small molecule | |
Experimental | DB02207 | 7-Nitroindazole | Small molecule | |
Experimental | DB02234 | Ethylisothiourea | Small molecule | |
Experimental | DB02462 | Thiocoumarin | Small molecule | |
Experimental | DB02533 | Aminoguanidine | Small molecule | |
Experimental | DB02539 | S-Ethylisothiourea | Small molecule | |
Experimental | DB02644 | N-Omega-Propyl-L-Arginine | Small molecule | |
Experimental | DB02692 | (6r,1'r,2's)-5,6,7,8 Tetrahydrobiopterin | Small molecule | |
Experimental | DB03100 | 6-Nitroindazole | Small molecule | |
Experimental | DB03144 | N-Omega-Hydroxy-L-Arginine | Small molecule | |
Experimental | DB03449 | N-(4-(2-((3-Chlorophenylmethyl)Amino)Ethyl)Phenyl)-2-Thiophecarboxamidine | Small molecule | |
Experimental | DB03953 | L-Thiocitrulline | Small molecule | |
Experimental | DB04400 | 7,8-Dihydrobiopterin | Small molecule | |
Experimental | DB04534 | 5-Nitroindazole | Small molecule | |
Investigational | DB05214 | KD7040 | Small molecule | |
Investigational | DB05252 | ACCLAIM | Small molecule | |
Experimental | DB06879 | 5-(4'-AMINO-1'-ETHYL-5',8'-DIFLUORO-1'H-SPIRO[PIPERIDINE-4,2'-QUINAZOLINE]-1-YLCARBONYL)PICOLINONITRILE | Small molecule | |
Experimental | DB06916 | N-[2-(1,3-BENZODIOXOL-5-YL)ETHYL]-1-[2-(1H-IMIDAZOL-1-YL)-6-METHYLPYRIMIDIN-4-YL]-D-PROLINAMIDE | Small molecule | |
Experimental | DB07002 | 4-({4-[(4-methoxypyridin-2-yl)amino]piperidin-1-yl}carbonyl)benzonitrile | Small molecule | |
Experimental | DB07003 | (2S)-2-methyl-2,3-dihydrothieno[2,3-f][1,4]oxazepin-5-amine | Small molecule | |
Experimental | DB07007 | (3R)-3-[(1,2,3,4-tetrahydroisoquinolin-7-yloxy)methyl]-2,3-dihydrothieno[2,3-f][1,4]oxazepin-5-amine | Small molecule | |
Experimental | DB07008 | 4-(1,3-BENZODIOXOL-5-YLOXY)-2-[4-(1H-IMIDAZOL-1-YL)PHENOXY]PYRIMIDINE | Small molecule | |
Experimental | DB07011 | (3S)-1-(1,3-BENZODIOXOL-5-YLMETHYL)-3-[4-(1H-IMIDAZOL-1-YL)PHENOXY]PIPERIDINE | Small molecule | |
Experimental | DB07029 | 4-(1,3-BENZODIOXOL-5-YLOXY)-2-[4-(1H-IMIDAZOL-1-YL)PHENOXY]-6-METHYLPYRIMIDINE | Small molecule | |
Experimental | DB07306 | ETHYL 4-[(4-CHLOROPYRIDIN-2-YL)AMINO]PIPERIDINE-1-CARBOXYLATE | Small molecule | |
Experimental | DB07318 | N-[2-(4-AMINO-5,8-DIFLUORO-1,2-DIHYDROQUINAZOLIN-2-YL)ETHYL]-3-FURAMIDE | Small molecule | |
Experimental | DB07388 | ETHYL 4-[(4-METHYLPYRIDIN-2-YL)AMINO]PIPERIDINE-1-CARBOXYLATE | Small molecule | |
Experimental | DB07389 | N-[2-(6-AMINO-4-METHYLPYRIDIN-2-YL)ETHYL]-4-CYANOBENZAMIDE | Small molecule | |
Experimental | DB07405 | 1-(6-CYANO-3-PYRIDYLCARBONYL)-5',8'-DIFLUOROSPIRO[PIPERIDINE-4,2'(1'H)-QUINAZOLINE]-4'-AMINE | Small molecule | |
Experimental | DB08214 | 4-(1H-IMIDAZOL-1-YL)PHENOL | Small molecule | |
Experimental | DB08750 | 1-[4-(AMINOMETHYL)BENZOYL]-5'-FLUORO-1'H-SPIRO[PIPERIDINE-4,2'-QUINAZOLIN]-4'-AMINE | Small molecule | |
Approved | DB08814 | Triflusal | Small molecule |
Gene-centered ligand-gene interaction network |
Ligands binding to mutated ligand binding site of NOS2 go to BioLip |
Ligand ID | Ligand short name | Ligand long name | PDB ID | PDB name | mutLBS | ZN | ZINC(2+) | 1nsi | A | C115 | ZN | ZINC(2+) | 1nsi | B | C115 | ZN | ZINC(2+) | 1nsi | C | C115 | ZN | ZINC(2+) | 1nsi | D | C115 | ZN | ZINC(2+) | 3e7g | A | C115 | ZN | ZINC(2+) | 3e7g | B | C115 | ZN | ZINC(2+) | 3e7g | C | C115 | ZN | ZINC(2+) | 3e7g | D | C115 | ZN | ZINC(2+) | 3ej8 | A | C115 | ZN | ZINC(2+) | 3ej8 | B | C115 | ZN | ZINC(2+) | 3ej8 | C | C115 | ZN | ZINC(2+) | 3ej8 | D | C115 | ZN | ZINC(2+) | 4nos | A | C115 | ZN | ZINC(2+) | 4nos | B | C115 | ZN | ZINC(2+) | 4nos | C | C115 | ZN | ZINC(2+) | 4nos | D | C115 | H4B | 5,6,7,8-TETRAHYDROBIOPTERIN | 2nsi | A | H477 | H4B | 5,6,7,8-TETRAHYDROBIOPTERIN | 2nsi | C | H477 | H4B | 5,6,7,8-TETRAHYDROBIOPTERIN | 3e7g | A | H477 | H4B | 5,6,7,8-TETRAHYDROBIOPTERIN | 3e7g | B | H477 | H4B | 5,6,7,8-TETRAHYDROBIOPTERIN | 3ej8 | A | H477 | H4B | 5,6,7,8-TETRAHYDROBIOPTERIN | 3ej8 | B | H477 | H4B | 5,6,7,8-TETRAHYDROBIOPTERIN | 1nsi | A | H477 E479 | H4B | 5,6,7,8-TETRAHYDROBIOPTERIN | 1nsi | B | H477 E479 | H4B | 5,6,7,8-TETRAHYDROBIOPTERIN | 1nsi | C | H477 E479 | H4B | 5,6,7,8-TETRAHYDROBIOPTERIN | 1nsi | D | H477 E479 | H4B | 5,6,7,8-TETRAHYDROBIOPTERIN | 2nsi | B | H477 E479 | H4B | 5,6,7,8-TETRAHYDROBIOPTERIN | 2nsi | D | H477 E479 | H4B | 5,6,7,8-TETRAHYDROBIOPTERIN | 3e7g | D | H477 E479 | H4B | 5,6,7,8-TETRAHYDROBIOPTERIN | 4nos | A | H477 E479 | H2B | QUINONOID 7,8-TETRAHYDROBIOPTERIN | 4nos | B | H477 E479 | H4B | 5,6,7,8-TETRAHYDROBIOPTERIN | 4nos | C | H477 E479 | H4B | 5,6,7,8-TETRAHYDROBIOPTERIN | 4nos | D | H477 E479 | H4B | 5,6,7,8-TETRAHYDROBIOPTERIN | 4cx7 | A | H477 E479 | H4B | 5,6,7,8-TETRAHYDROBIOPTERIN | 4cx7 | B | H477 E479 | H4B | 5,6,7,8-TETRAHYDROBIOPTERIN | 4cx7 | C | H477 E479 | H4B | 5,6,7,8-TETRAHYDROBIOPTERIN | 4cx7 | D | H477 E479 | FMN | FLAVIN MONONUCLEOTIDE | 3hr4 | A | S550 F593 Q665 | FMN | FLAVIN MONONUCLEOTIDE | 3hr4 | C | S550 F593 Q665 | FMN | FLAVIN MONONUCLEOTIDE | 3hr4 | E | S550 F593 Q665 | FMN | FLAVIN MONONUCLEOTIDE | 3hr4 | G | S550 F593 Q665 | HEC | FERROHEME C(2-) | 3ej8 | B | W194 S242 M434 Y489 Y491 | HEM | HEME B | 1nsi | C | W194 S242 Y489 Y491 | HEM | HEME B | 3e7g | A | W194 S242 Y489 Y491 | HEM | HEME B | 3e7g | B | W194 S242 Y489 Y491 | HEM | HEME B | 3e7g | C | W194 S242 Y489 Y491 | HEM | HEME B | 3e7g | D | W194 S242 Y489 Y491 | HEC | FERROHEME C(2-) | 3ej8 | A | W194 S242 Y489 Y491 | HEM | HEME B | 4nos | A | W194 S242 Y489 Y491 | HEM | HEME B | 4nos | B | W194 S242 Y489 Y491 | HEM | HEME B | 4nos | C | W194 S242 Y489 Y491 | HEM | HEME B | 4nos | D | W194 S242 Y489 Y491 | HEM | HEME B | 4cx7 | A | W194 S242 Y489 Y491 | HEM | HEME B | 4cx7 | C | W194 S242 Y489 Y491 | HEM | HEME B | 1nsi | A | W194 S242 Y491 | HEM | HEME B | 2nsi | A | W194 S242 Y491 | HEM | HEME B | 2nsi | B | W194 S242 Y491 | HEM | HEME B | 2nsi | C | W194 S242 Y491 | HEM | HEME B | 2nsi | D | W194 S242 Y491 | HEM | HEME B | 1nsi | B | W194 Y489 Y491 | HEC | FERROHEME C(2-) | 3ej8 | C | W194 Y489 Y491 | HEC | FERROHEME C(2-) | 3ej8 | D | W194 Y489 Y491 | HEM | HEME B | 4cx7 | B | W194 Y489 Y491 | HEM | HEME B | 1nsi | D | W194 Y491 | HEM | HEME B | 4cx7 | D | W194 Y491 | H4B | 5,6,7,8-TETRAHYDROBIOPTERIN | 3ej8 | C | W90 H477 | H4B | 5,6,7,8-TETRAHYDROBIOPTERIN | 3e7g | C | W90 H477 E479 | ARG | ARGININE | 1nsi | A | Y347 | ARG | ARGININE | 1nsi | B | Y347 | AT2 | ETHYL 4-[(4-METHYLPYRIDIN-2-YL)AMINO]PIPERIDINE-1-CARBOXYLATE | 3e7g | A | Y347 | AT2 | ETHYL 4-[(4-METHYLPYRIDIN-2-YL)AMINO]PIPERIDINE-1-CARBOXYLATE | 3e7g | B | Y347 | AT2 | ETHYL 4-[(4-METHYLPYRIDIN-2-YL)AMINO]PIPERIDINE-1-CARBOXYLATE | 3e7g | C | Y347 | AT2 | ETHYL 4-[(4-METHYLPYRIDIN-2-YL)AMINO]PIPERIDINE-1-CARBOXYLATE | 3e7g | D | Y347 | S71 | (R)-6-(3-AMINO-2-(5-(2-(6-AMINO-4- METHYLPYRIDIN-2-YL)ETHYL)PYRIDIN-3-YL)PROPYL)-4- METHYLPYRIDIN-2-AMINE | 4cx7 | A | Y491 | S71 | (R)-6-(3-AMINO-2-(5-(2-(6-AMINO-4- METHYLPYRIDIN-2-YL)ETHYL)PYRIDIN-3-YL)PROPYL)-4- METHYLPYRIDIN-2-AMINE | 4cx7 | B | Y491 | S71 | (R)-6-(3-AMINO-2-(5-(2-(6-AMINO-4- METHYLPYRIDIN-2-YL)ETHYL)PYRIDIN-3-YL)PROPYL)-4- METHYLPYRIDIN-2-AMINE | 4cx7 | C | Y491 | S71 | (R)-6-(3-AMINO-2-(5-(2-(6-AMINO-4- METHYLPYRIDIN-2-YL)ETHYL)PYRIDIN-3-YL)PROPYL)-4- METHYLPYRIDIN-2-AMINE | 4cx7 | D | Y491 |
Top |
Conservation information for LBS of NOS2 |
Multiple alignments for P35228 in multiple species |
LBS | AA sequence | # species | Species | A197 | QAWRNAPRCIG | 3 | Homo sapiens, Gallus gallus, Bos taurus | A197 | MAWRNAPRCIG | 2 | Mus musculus, Rattus norvegicus | C110 | KGILTCRSKSC | 1 | Homo sapiens | C110 | KEVINCRTRAC | 1 | Gallus gallus | C110 | TSDFTCKSKSC | 1 | Mus musculus | C110 | TSDISCKSKLC | 1 | Rattus norvegicus | C110 | KGDLSCKSKSC | 1 | Bos taurus | C115 | CRSKSCLGSIM | 1 | Homo sapiens | C115 | CRTRACQGALM | 1 | Gallus gallus | C115 | CKSKSCLGSIM | 1 | Mus musculus | C115 | CKSKLCMGSIM | 1 | Rattus norvegicus | C115 | CKSKSCLASIM | 1 | Bos taurus | C200 | RNAPRCIGRIQ | 5 | Homo sapiens, Gallus gallus, Mus musculus, Rattus norvegicus, Bos taurus | C635 | MYPQFCAFAHD | 3 | Mus musculus, Rattus norvegicus, Bos taurus | C635 | MYPRFCAFAHD | 1 | Homo sapiens | C635 | MYPEFCAFAHA | 1 | Gallus gallus | D382 | EIGVRDFCDVQ | 2 | Homo sapiens, Gallus gallus | D382 | EIGVRDFCDTQ | 2 | Mus musculus, Rattus norvegicus | D382 | EVGVRDFCDAQ | 1 | Bos taurus | E377 | WYMGTEIGVRD | 4 | Homo sapiens, Gallus gallus, Mus musculus, Rattus norvegicus | E377 | WYMGTEVGVRD | 1 | Bos taurus | E479 | PVFHQEMLNYV | 5 | Homo sapiens, Gallus gallus, Mus musculus, Rattus norvegicus, Bos taurus | E546 | VLFATETGKSE | 2 | Mus musculus, Rattus norvegicus | E546 | ILFATETGKSE | 1 | Homo sapiens | E546 | VIYATETGKSE | 1 | Gallus gallus | E546 | ILFATETGRSE | 1 | Bos taurus | E661 | TGEGDELSGQE | 3 | Mus musculus, Rattus norvegicus, Bos taurus | E661 | MGEGDELSGQE | 1 | Homo sapiens | E661 | VGEGDELNGQE | 1 | Gallus gallus | F369 | FPGCPFNGWYM | 2 | Homo sapiens, Bos taurus | F369 | FPACPFNGWYM | 2 | Mus musculus, Rattus norvegicus | F369 | FTACPFNGWYM | 1 | Gallus gallus | F476 | SITPVFHQEML | 5 | Homo sapiens, Gallus gallus, Mus musculus, Rattus norvegicus, Bos taurus | F593 | VVTSTFGNGDC | 3 | Homo sapiens, Mus musculus, Rattus norvegicus | F593 | VVTSTFGNGDS | 2 | Gallus gallus, Bos taurus | F634 | SMYPQFCAFAH | 3 | Mus musculus, Rattus norvegicus, Bos taurus | F634 | SMYPRFCAFAH | 1 | Homo sapiens | F634 | TMYPEFCAFAH | 1 | Gallus gallus | G202 | APRCIGRIQWS | 5 | Homo sapiens, Gallus gallus, Mus musculus, Rattus norvegicus, Bos taurus | G371 | ACPFNGWYMGT | 3 | Gallus gallus, Mus musculus, Rattus norvegicus | G371 | GCPFNGWYMGT | 2 | Homo sapiens, Bos taurus | G548 | FATETGKSEAL | 3 | Homo sapiens, Mus musculus, Rattus norvegicus | G548 | YATETGKSETL | 1 | Gallus gallus | G548 | FATETGRSETL | 1 | Bos taurus | G594 | VTSTFGNGDCP | 3 | Homo sapiens, Mus musculus, Rattus norvegicus | G594 | VTSTFGNGDSP | 2 | Gallus gallus, Bos taurus | G596 | STFGNGDCPSN | 2 | Mus musculus, Rattus norvegicus | G596 | STFGNGDCPGN | 1 | Homo sapiens | G596 | STFGNGDSPNN | 1 | Gallus gallus | G596 | STFGNGDSPGN | 1 | Bos taurus | G627 | AVFGLGSSMYP | 4 | Homo sapiens, Mus musculus, Rattus norvegicus, Bos taurus | G627 | AVFGLGSTMYP | 1 | Gallus gallus | H477 | ITPVFHQEMLN | 5 | Homo sapiens, Gallus gallus, Mus musculus, Rattus norvegicus, Bos taurus | I201 | NAPRCIGRIQW | 5 | Homo sapiens, Gallus gallus, Mus musculus, Rattus norvegicus, Bos taurus | I462 | CPADWIWLVPP | 4 | Homo sapiens, Mus musculus, Rattus norvegicus, Bos taurus | I462 | CPADWVWIVPP | 1 | Gallus gallus | K549 | ATETGKSEALA | 3 | Homo sapiens, Mus musculus, Rattus norvegicus | K549 | ATETGKSETLA | 1 | Gallus gallus | K549 | ATETGRSETLA | 1 | Bos taurus | L209 | IQWSNLQVFDA | 5 | Homo sapiens, Gallus gallus, Mus musculus, Rattus norvegicus, Bos taurus | L626 | YAVFGLGSSMY | 4 | Homo sapiens, Mus musculus, Rattus norvegicus, Bos taurus | L626 | YAVFGLGSTMY | 1 | Gallus gallus | M120 | CLGSIMTPKSL | 1 | Homo sapiens | M120 | CQGALMTPKGL | 1 | Gallus gallus | M120 | CLGSIMNPKSL | 1 | Mus musculus | M120 | CMGSIMNSKSL | 1 | Rattus norvegicus | M120 | CLASIMNPKSL | 1 | Bos taurus | M355 | PAVANMLLEVG | 5 | Homo sapiens, Gallus gallus, Mus musculus, Rattus norvegicus, Bos taurus | M374 | FNGWYMGTEIG | 4 | Homo sapiens, Gallus gallus, Mus musculus, Rattus norvegicus | M374 | FNGWYMGTEVG | 1 | Bos taurus | M434 | QNVTIMDHHSA | 3 | Homo sapiens, Gallus gallus, Bos taurus | M434 | QNVTIMDHHTA | 2 | Mus musculus, Rattus norvegicus | N370 | PGCPFNGWYMG | 2 | Homo sapiens, Bos taurus | N370 | PACPFNGWYMG | 2 | Mus musculus, Rattus norvegicus | N370 | TACPFNGWYMG | 1 | Gallus gallus | N595 | TSTFGNGDCPS | 2 | Mus musculus, Rattus norvegicus | N595 | TSTFGNGDCPG | 1 | Homo sapiens | N595 | TSTFGNGDSPN | 1 | Gallus gallus | N595 | TSTFGNGDSPG | 1 | Bos taurus | P350 | KWYALPAVANM | 5 | Homo sapiens, Gallus gallus, Mus musculus, Rattus norvegicus, Bos taurus | Q205 | CIGRIQWSNLQ | 5 | Homo sapiens, Gallus gallus, Mus musculus, Rattus norvegicus, Bos taurus | Q263 | RVWNAQLIRYA | 2 | Homo sapiens, Bos taurus | Q263 | RVWNSQLIRYA | 1 | Gallus gallus | Q263 | RLWNSQLIRYA | 1 | Mus musculus | Q263 | RIWNSQLIRYA | 1 | Rattus norvegicus | Q478 | TPVFHQEMLNY | 5 | Homo sapiens, Gallus gallus, Mus musculus, Rattus norvegicus, Bos taurus | Q665 | DELSGQEDAFR | 3 | Homo sapiens, Mus musculus, Rattus norvegicus | Q665 | DELNGQEEAFR | 1 | Gallus gallus | Q665 | DELSGQEEAFR | 1 | Bos taurus | R199 | WRNAPRCIGRI | 5 | Homo sapiens, Gallus gallus, Mus musculus, Rattus norvegicus, Bos taurus | R266 | NSQLIRYAGYQ | 3 | Gallus gallus, Mus musculus, Rattus norvegicus | R266 | NAQLIRYAGYQ | 2 | Homo sapiens, Bos taurus | R381 | TEIGVRDFCDV | 2 | Homo sapiens, Gallus gallus | R381 | TEIGVRDFCDT | 2 | Mus musculus, Rattus norvegicus | R381 | TEVGVRDFCDA | 1 | Bos taurus | R388 | FCDTQRYNILE | 2 | Mus musculus, Rattus norvegicus | R388 | FCDVQRYNILE | 1 | Homo sapiens | R388 | FCDVQRYNILK | 1 | Gallus gallus | R388 | FCDAQRYNILE | 1 | Bos taurus | R633 | SSMYPQFCAFA | 3 | Mus musculus, Rattus norvegicus, Bos taurus | R633 | SSMYPRFCAFA | 1 | Homo sapiens | R633 | STMYPEFCAFA | 1 | Gallus gallus | S118 | KSCLGSIMTPK | 1 | Homo sapiens | S118 | RACQGALMTPK | 1 | Gallus gallus | S118 | KSCLGSIMNPK | 1 | Mus musculus | S118 | KLCMGSIMNSK | 1 | Rattus norvegicus | S118 | KSCLASIMNPK | 1 | Bos taurus | S242 | NGNIRSAITVF | 3 | Homo sapiens, Mus musculus, Bos taurus | S242 | NGNIRSAITIF | 1 | Gallus gallus | S242 | SGNIRSAITVF | 1 | Rattus norvegicus | S550 | TETGKSEALAR | 2 | Mus musculus, Rattus norvegicus | S550 | TETGKSEALAW | 1 | Homo sapiens | S550 | TETGKSETLAN | 1 | Gallus gallus | S550 | TETGRSETLAQ | 1 | Bos taurus | S591 | LLVVTSTFGNG | 5 | Homo sapiens, Gallus gallus, Mus musculus, Rattus norvegicus, Bos taurus | S628 | VFGLGSSMYPQ | 3 | Mus musculus, Rattus norvegicus, Bos taurus | S628 | VFGLGSSMYPR | 1 | Homo sapiens | S628 | VFGLGSTMYPE | 1 | Gallus gallus | T121 | LGSIMTPKSLT | 1 | Homo sapiens | T121 | QGALMTPKGLV | 1 | Gallus gallus | T121 | LGSIMNPKSLT | 1 | Mus musculus | T121 | MGSIMNSKSLT | 1 | Rattus norvegicus | T121 | LASIMNPKSLT | 1 | Bos taurus | T545 | TVLFATETGKS | 2 | Mus musculus, Rattus norvegicus | T545 | TILFATETGKS | 1 | Homo sapiens | T545 | TVIYATETGKS | 1 | Gallus gallus | T545 | TILFATETGRS | 1 | Bos taurus | T547 | LFATETGKSEA | 3 | Homo sapiens, Mus musculus, Rattus norvegicus | T547 | IYATETGKSET | 1 | Gallus gallus | T547 | LFATETGRSET | 1 | Bos taurus | T592 | LVVTSTFGNGD | 5 | Homo sapiens, Gallus gallus, Mus musculus, Rattus norvegicus, Bos taurus | V352 | YALPAVANMLL | 5 | Homo sapiens, Gallus gallus, Mus musculus, Rattus norvegicus, Bos taurus | W194 | ATKQAWRNAPR | 2 | Homo sapiens, Bos taurus | W194 | ATKMAWRNAPR | 2 | Mus musculus, Rattus norvegicus | W194 | AAKQAWRNAPR | 1 | Gallus gallus | W372 | CPFNGWYMGTE | 5 | Homo sapiens, Gallus gallus, Mus musculus, Rattus norvegicus, Bos taurus | W461 | GCPADWIWLVP | 4 | Homo sapiens, Mus musculus, Rattus norvegicus, Bos taurus | W461 | GCPADWVWIVP | 1 | Gallus gallus | W463 | PADWIWLVPPV | 2 | Mus musculus, Rattus norvegicus | W463 | PADWIWLVPPM | 1 | Homo sapiens | W463 | PADWVWIVPPM | 1 | Gallus gallus | W463 | PADWIWLVPPI | 1 | Bos taurus | W90 | VRIKNWGSGMT | 1 | Homo sapiens | W90 | VKVRNMENGSS | 1 | Gallus gallus | W90 | VRIKNWGSGEI | 1 | Mus musculus | W90 | VRIKNWGNGEI | 1 | Rattus norvegicus | W90 | VRIKNWGSGVT | 1 | Bos taurus | Y347 | LELKWYALPAV | 2 | Homo sapiens, Bos taurus | Y347 | LGLKWYALPAV | 2 | Mus musculus, Rattus norvegicus | Y347 | LDLKWYALPAV | 1 | Gallus gallus | Y373 | PFNGWYMGTEI | 4 | Homo sapiens, Gallus gallus, Mus musculus, Rattus norvegicus | Y373 | PFNGWYMGTEV | 1 | Bos taurus | Y489 | VLSPFYYYQVE | 2 | Homo sapiens, Bos taurus | Y489 | VLSPFYYYQIE | 2 | Mus musculus, Rattus norvegicus | Y489 | VLTPFFYYQVD | 1 | Gallus gallus | Y491 | SPFYYYQIEPW | 2 | Mus musculus, Rattus norvegicus | Y491 | SPFYYYQVEAW | 1 | Homo sapiens | Y491 | TPFFYYQVDAW | 1 | Gallus gallus | Y491 | SPFYYYQVEPW | 1 | Bos taurus | Y631 | LGSSMYPQFCA | 3 | Mus musculus, Rattus norvegicus, Bos taurus | Y631 | LGSSMYPRFCA | 1 | Homo sapiens | Y631 | LGSTMYPEFCA | 1 | Gallus gallus |
Copyright © 2016-Present - The University of Texas Health Science Center at Houston |